Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples.
Black MA, Shen G, Feng X, Garcia Beltran WF, Feng Y, Vasudevaraja V, Allison D, Lin LH, Gindin T, Astudillo M, Yang D, Murali M, Iafrate AJ, Jour G, Cotzia P, Snuderl M. Black MA, et al. Among authors: vasudevaraja v. J Immunol Methods. 2021 Feb;489:112909. doi: 10.1016/j.jim.2020.112909. Epub 2020 Nov 7. J Immunol Methods. 2021. PMID: 33166549 Free PMC article.
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant Glioma.
Spino M, Kurz SC, Chiriboga L, Serrano J, Zeck B, Sen N, Patel S, Shen G, Vasudevaraja V, Tsirigos A, Suryadevara CM, Frenster JD, Tateishi K, Wakimoto H, Jain R, Riina HA, Nicolaides TP, Sulman EP, Cahill DP, Golfinos JG, Isse K, Saunders LR, Zagzag D, Placantonakis DG, Snuderl M, Chi AS. Spino M, et al. Among authors: vasudevaraja v. Clin Cancer Res. 2019 Feb 15;25(4):1261-1271. doi: 10.1158/1078-0432.CCR-18-2312. Epub 2018 Nov 5. Clin Cancer Res. 2019. PMID: 30397180 Free PMC article.
GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
Richardson TE, Tang K, Vasudevaraja V, Serrano J, William CM, Mirchia K, Pierson CR, Leonard JR, AbdelBaki MS, Schieffer KM, Cottrell CE, Tovar-Spinoza Z, Comito MA, Boué DR, Jour G, Snuderl M. Richardson TE, et al. Among authors: vasudevaraja v. J Neuropathol Exp Neurol. 2019 Dec 1;78(12):1089-1099. doi: 10.1093/jnen/nlz093. J Neuropathol Exp Neurol. 2019. PMID: 31626289
Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers.
Bledea R, Vasudevaraja V, Patel S, Stafford J, Serrano J, Esposito G, Tredwin LM, Goodman N, Kloetgen A, Golfinos JG, Zagzag D, Weigelt B, Iafrate AJ, Sulman EP, Chi AS, Dogan S, Reis-Filho JS, Chiang S, Placantonakis D, Tsirigos A, Snuderl M. Bledea R, et al. Among authors: vasudevaraja v. Sci Rep. 2019 Nov 14;9(1):16830. doi: 10.1038/s41598-019-53262-7. Sci Rep. 2019. PMID: 31727977 Free PMC article.
Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma.
Pradhan D, Jour G, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman EP, Diab A, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Pradhan D, et al. Among authors: vasudevaraja v. Cancers (Basel). 2019 Dec 16;11(12):2031. doi: 10.3390/cancers11122031. Cancers (Basel). 2019. PMID: 31888295 Free PMC article.
Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy.
Cui X, Ma C, Vasudevaraja V, Serrano J, Tong J, Peng Y, Delorenzo M, Shen G, Frenster J, Morales RT, Qian W, Tsirigos A, Chi AS, Jain R, Kurz SC, Sulman EP, Placantonakis DG, Snuderl M, Chen W. Cui X, et al. Among authors: vasudevaraja v. Elife. 2020 Sep 10;9:e52253. doi: 10.7554/eLife.52253. Elife. 2020. PMID: 32909947 Free PMC article.
42 results